Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
18 January 1996Website:
http://www.titanpharm.comNext earnings report:
14 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Thu, 27 Jun 2024 23:31:12 GMTDividend
Analysts recommendations
Institutional Ownership
What type of business is Titan Pharmaceuticals?
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the European Union. It is also developing kappa opioid agonist peptide program (TP-2021) for use in combination with ProNeura technology for the treatment of chronic pruritus; nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder; and other programs, including HIV preventative therapeutic and a contraceptive from a single ProNeura implant for women and adolescent girls. The company was incorporated in 1992 and is based in South San Francisco, California.
What sector is Titan Pharmaceuticals in?
Titan Pharmaceuticals is in the Healthcare sector
What industry is Titan Pharmaceuticals in?
Titan Pharmaceuticals is in the Biotechnology industry
What country is Titan Pharmaceuticals from?
Titan Pharmaceuticals is headquartered in United States
When did Titan Pharmaceuticals go public?
Titan Pharmaceuticals initial public offering (IPO) was on 18 January 1996
What is Titan Pharmaceuticals website?
https://www.titanpharm.com
Is Titan Pharmaceuticals in the S&P 500?
No, Titan Pharmaceuticals is not included in the S&P 500 index
Is Titan Pharmaceuticals in the NASDAQ 100?
No, Titan Pharmaceuticals is not included in the NASDAQ 100 index
Is Titan Pharmaceuticals in the Dow Jones?
No, Titan Pharmaceuticals is not included in the Dow Jones index
When does Titan Pharmaceuticals report earnings?
The next expected earnings date for Titan Pharmaceuticals is 14 August 2024